JANUX THERAPEUTICS INC

Ticker: JANX CUSIP: 47103J105 Class: Common Stock

Paradigm Biocapital Advisors LP's Holding History (CIK: 0001855655)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 2,920,258 Value ($000) $71,371 Avg Close $24.35 Range $21.73 - $28.39

Q2 2025

Shares 2,920,258 Value ($000) $67,458 Avg Close $26.35 Range $22.48 - $33.97

Q1 2025

Shares 3,329,909 Value ($000) $89,908 Avg Close $37.69 Range $26.39 - $61.59

Q4 2024

Shares 3,515,986 Value ($000) $188,246 Avg Close $52.89 Range $40.02 - $71.71

Q3 2024

Shares 2,400,574 Value ($000) $109,058 Avg Close $43.50 Range $34.51 - $52.23

Q2 2024

Shares 1,564,452 Value ($000) $65,535 Avg Close $46.95 Range $34.63 - $65.60

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	2,920,258	$71,371	$24.35	$21.73 - $28.39
Q2 2025	2,920,258	$67,458	$26.35	$22.48 - $33.97
Q1 2025	3,329,909	$89,908	$37.69	$26.39 - $61.59
Q4 2024	3,515,986	$188,246	$52.89	$40.02 - $71.71
Q3 2024	2,400,574	$109,058	$43.50	$34.51 - $52.23
Q2 2024	1,564,452	$65,535	$46.95	$34.63 - $65.60